Trials
Search / Trial NCT05654545

Smoking Cessation Coaching in High-Risk Situations: A Virtual Reality Study

Launched by LEIDEN UNIVERSITY MEDICAL CENTER · Dec 8, 2022

Apply for Trial

Trial Information

Current as of January 16, 2025

Completed

Keywords

Smoking Cessation Coaching Chatbot High Risk Situations E Health Virtual Reality Smoking Relapse Prevention

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • • 18 years or older
  • • Being able to read and understand Dutch
  • • Smoking ≥ 10 cigarettes a day
  • • Intention to quit smoking sometime in the future
  • • Being able to wear a VR helmet for approximately 30 minutes, with breaks in between
  • • Willingness to take and send videos and audio of three locations where the participant is most likely to smoke (i.e., highest chance of smoking when in the environment)
  • Exclusion Criteria:
  • • Visual problems (e.g., limited visibility without glasses) that affect viewing VR environments (based on self-report)
  • • Currently involved in smoking cessation activity or therapy (based on self-report)
  • • When patients are deemed unfit to participate (due to, for example, psychological problems or medication). This decision is left to the discretion of the responsible researcher.

Trial Officials

Anke Versluis, Dr.

Principal Investigator

Leiden University Medical Center (LUMC)

Eline Meijer, Dr.

Principal Investigator

Leiden University Medical Center (LUMC)

About Leiden University Medical Center

Leiden University Medical Center (LUMC) is a prominent academic medical center located in the Netherlands, renowned for its commitment to advancing healthcare through innovative research and high-quality patient care. As a clinical trial sponsor, LUMC focuses on translating scientific discoveries into effective therapies, fostering collaborations between researchers, clinicians, and industry partners. The center is dedicated to conducting rigorous clinical studies across various medical fields, ensuring adherence to ethical standards and regulatory requirements while prioritizing patient safety and outcomes. Through its multidisciplinary approach, LUMC aims to contribute significantly to the understanding and treatment of complex health conditions, driving progress in personalized medicine and improving global health.

Locations

Leiden, Zuid Holland, Netherlands

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0

Similar Trials